Vaccine Partner Valneva receives FDA approval for the World’s first chikungunya vaccine using Albumedix’ Recombumin®
(Adnkronos) – Albumedix Ltd (‘Albumedix’), now part of the life science group Sartorius, announces that Recombumin® is critical to the manufacture of the first FDA- licensed chikungunya vaccine. NOTTINGHAM, England, Nov.
